In a final display of the "buy-the-dip" mentality that has defined the year, high-growth "rocket names" led a dramatic intraday recovery on Tuesday, signaling that investor appetite for aggressive growth remains insatiable as the market prepares for 2026. After an early morning swoon that saw major indices dip on profit-taking,
As the sun sets on 2025, the S&P 500 is holding its breath. In a trading session characterized by thin holiday volume and a notable absence of institutional conviction, the benchmark index spent much of Tuesday, December 30, 2025, hovering precariously around the flatline. Trading near the 6,910
As the final trading days of 2025 unfold, the Nasdaq 100 is struggling to find a clear path forward, characterized by thin holiday volume and a lack of immediate catalysts. On Tuesday, December 30, 2025, the tech-heavy index hovered near the 25,520 mark, reflecting a marginal decline as investors
As 2025 draws to a close, the gold market is witnessing a monumental shift that has fundamentally altered the balance sheets of the world’s largest miners. After a period of relative stagnation and sell-offs earlier in the decade, bullion prices have staged a historic recovery, surging to an all-time
As the curtain closes on 2025, the financial landscape presents a tale of two markets. While the S&P 500 (NYSEARCA: SPY) hovers near the historic 7,000-point milestone, fueled by a 19% year-to-date rally and a resilient "soft landing" for the U.S. economy, a stark divergence has emerged
The Dow Jones Industrial Average (DJIA) is facing a critical juncture as the 2025 trading year draws to a close. After a volatile month marked by a record-breaking "Santa Claus Rally" followed by a sharp three-session pullback, the blue-chip index is currently testing key technical support levels that could determine
As 2025 draws to a close, the global financial landscape is being reshaped by a rare convergence of seismic geopolitical shifts and a fundamental recalibration of U.S. monetary policy. The final week of December has seen investor sentiment swing between euphoria and caution as the prospect of a definitive
As the final trading days of 2025 wind down, Rhythm Pharmaceuticals (Nasdaq: RYTM) finds itself at a critical crossroads. After a meteoric rise that saw the stock gain over 100% through the first three quarters of the year, the rare-disease specialist has encountered a late-year slump, retreating from its 52-week
As the final trading days of 2025 come to a close, the financial world is looking back at a year defined by the "Quantum Summer," a period of explosive growth and speculative fervor that saw D-Wave Quantum Inc. (NYSE: QBTS) transform from a speculative penny stock into a high-stakes battleground
